The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use within the European Union, concluded a vote on Monday evening in Brussels following three rounds of voting. “We are delighted, it was very…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease patients and their families. Karel Fol, the country manager…
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the Dutch ambition to be a frontrunner in new healthcare challenges also comprises an…
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands nevertheless still sits in fourth position on the 2015…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease patients and their families. Karel Fol, the country manager for Benelux shares the plans of the company for the Netherlands and Benelux, how Sobi is transforming its product portfolio, and how co-creation is at the core of this transformation.…
Register now>> Health and health care have made exponential progress over the course of a century. But inequalities are still rife. While statistically we enjoy much longer lifespans and…
Register now>> Health and health care have made exponential progress over the course of a century. But inequalities are still rife. While statistically we enjoy much longer lifespans and…
Register now>> Health and health care have made exponential progress over the course of a century. But inequalities are still rife. While statistically we enjoy much longer lifespans and…
See our Cookie Privacy Policy Here